Targretin
- Product NDC
- 0187-5526
- 11-digit product format
- 001875526
- Labeler code
- 0187
- Product ID
- 0187-5526_48a80386-cbef-4555-95fe-36bbfafcd760
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bexarotene
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- Bausch Health US, LLC
- Application
- NDA021055
- Marketing category
- NDA
- Marketing start
- 1999-12-29
- Substance
- BEXAROTENE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Retinoid [EPC], Retinoids [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Targretin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BEXAROTENE | 75 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | A61RXM4375 |
| Rxcui | 261349, 308725 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0187-5526-75 | Targretin | 1 in 1 CARTON | CAPSULE, LIQUID FILLED | 1 | | 15 |
| 0187-5526-75 | Targretin | 100 in 1 BOTTLE | CAPSULE, LIQUID FILLED | 100 | | 15 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| BEXAROTENE | ACTIVE INGREDIENT | A61RXM4375 | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| BEXAROTENE | ACTIVE MOIETY | A61RXM4375 | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| 1,4-SORBITAN | INACTIVE INGREDIENT | AV0YTZ4E6J | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [VALEANT PHARMACEUTICALS NORTH AMERICA LLC] | 6 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0187-5526 | TARGRETIN (BEXAROTENE) CAPSULE, LIQUID FILLED [BAUSCH HEALTH US, LLC] | 15 | Current NDC, Legacy NDC, 2 package rows | 20221208_1d056725-0576-4338-8089-6336e768ccdc.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0187-5526-75 | 00187552675 | 1 BOTTLE in 1 CARTON (0187-5526-75) / 100 CAPSULE, LIQUID FILLED in 1 BOTTLE | 1 bottle | 1999-12-29 | 0000-00-00 | No | No | Current |